The SCOPE 2025 Summit showcased a groundbreaking partnership between Mass General Brigham (MGB), AstraZeneca, and Evinova, highlighting how these...

C2N Diagnostics has received regulatory approval from the UK Medicines and Healthcare products Regulatory Agency (MHRA) for its PrecivityAD2...

LTZ Therapeutics received FDA clearance for its Investigational New Drug (IND) application for LTZ-301. LTZ-301, a first-in-class myeloid engager...

Regeneron Pharmaceuticals announced updated positive data from its ongoing Phase 1/2 CHORD trial of DB-OTO, a gene therapy for...

Gilead Sciences announced that the European Medicines Agency (EMA) has validated its Marketing Authorization Application (MAA) and EU-Medicines for...

NovelMed Therapeutics has received FDA clearance to initiate a Phase II efficacy trial of Ruxoprubart (NM8074) for Dermatomyositis (DM),...

Synergia Medical’s NAO.VNS™ device, implanted in five patients in Belgium, has met its primary safety endpoint in the AURORA...

MiNK Therapeutics presented Phase 2 data at the AACR IO Annual Meeting showcasing the potential of its allogeneic iNKT...

CytoDyn Inc. announced encouraging survival outcomes in a group of patients with metastatic triple-negative breast cancer (mTNBC) treated with...

PDS Biotechnology Corporation announced positive clinical trial results for its lead immunotherapy candidate, Versamune® HPV, in the treatment of...